We welcome O’Ryan and colleagues’ introspective tone and call for a “global conversation” on academia’s role in healthcare.1 Their article resonates with our thoughts and experiences in pain ...
Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful chemotherapy-induced peripheral neuropathy, researchers found.